SCHEMBL20150846

SCHEMBL20150846

OCCCCc1cc(Cl)nc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.44
RAD52 P43351 2/20 0.44
KDM4E B2RXH2 3/20 0.43
HTT P42858 2/20 0.42
USP2 O75604 2/20 0.42
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
JAK2 O60674 1/20 0.40
PDE5A O76074 1/20 0.40
ALDH1A1 P00352 2/20 0.39
GLA P06280 2/20 0.39
GAA P10253 2/20 0.39
MITF O75030 1/20 0.39
LMNA P02545 1/20 0.39
TTR P02766 1/20 0.39
RAB9A P51151 1/20 0.39
MAPT P10636 2/20 0.39
IGF1R P08069 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6983102 0.88 KDM4E (0.46) POLBRAD52KDM4EHTTUSP2
SCHEMBL3972718 0.83 KDM4E (0.50) POLBRAD52KDM4EHTTUSP2
Ammonia Solution, Strong SCHEMBL28150012 0.81 TLR8 (0.49) KDM4EUSP2ALDH1A1GLAGAA
SCHEMBL17471655 0.78 KDM4E (0.46) POLBRAD52KDM4EHTTUSP2
SCHEMBL6983097 0.78 KDM4E (0.46) POLBKDM4EHTTUSP2KMT2A
SCHEMBL27529063 0.77 KDM4E (0.50) POLBKDM4EHTTUSP2KMT2A
SCHEMBL11343689 0.77 KMT2A (0.53) POLBKDM4EHTTUSP2KMT2A
SCHEMBL30517871 0.77 KMT2A (0.53) POLBKDM4EHTTUSP2KMT2A
Hydrochloric Acid SCHEMBL6629225 0.75 KMT2A (0.52) POLBRAD52KDM4EHTTUSP2
SCHEMBL12020235 0.74 TLR7 (0.42) KDM4EHTTUSP2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134727-A1 Inhibitors of RAD52 Recombination Protein and Methods Using Same DREXEL UNIVERSITY (US) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134727-A1 Inhibitors of RAD52 Recombination Protein and Methods Using Same RAD52, RAD50, MRE11 POLB 146/4885RAD52 1/4885KDM4E 1934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.